Financhill
Sell
45

FELE Quote, Financials, Valuation and Earnings

Last price:
$97.13
Seasonality move :
1.91%
Day range:
$96.78 - $98.34
52-week range:
$91.67 - $111.94
Dividend yield:
1.04%
P/E ratio:
25.25x
P/S ratio:
2.23x
P/B ratio:
3.51x
Volume:
177.9K
Avg. volume:
296.4K
1-year change:
-8.85%
Market cap:
$4.4B
Revenue:
$2B
EPS (TTM):
$3.85

FELE Analysts' Consensus Rating

The 5 analysts providing 12-month price projections for Franklin Electric shares anticipate an average target of $109.00, ranging from a low estimate of $90.00 to a high estimate of $120.00. This average target implies a growth of 12.14% compared to the current stock price of $97.20.

Consensus Price Target

$109.00

Highest Price Target

$120.00

Lowest Price Target

$90.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 2 2

Hold 0 3 3

Sell 0 0 0
Consensus -- Hold Hold

FELE Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did HealthEquity Stock Fall So Much?
Why Did HealthEquity Stock Fall So Much?

HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…

Why Did Super Micro Stock Fall So Much?
Why Did Super Micro Stock Fall So Much?

Super Micro Computer (NASDAQ:SMCI) was once a highly popular stock…

Is Diamondback Energy a Good Stock to Buy?
Is Diamondback Energy a Good Stock to Buy?

Diamondback Energy (FANG) is a lesser-known diamond in the rough…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Buy
69
CNXC alert for Mar 28

Concentrix [CNXC] is up 42.45% over the past day.

Buy
74
SLNO alert for Mar 28

Soleno Therapeutics [SLNO] is up 37.64% over the past day.

Buy
72
WOR alert for Mar 28

Worthington Enterprises [WOR] is up 0.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock